Status:
COMPLETED
Nis Register Study Comparing Seroquel and Seroquel Prolong
Lead Sponsor:
AstraZeneca
Conditions:
Comparing Hospitalisation Time With Seroquel and Seroquel Prolong
Eligibility:
All Genders
Brief Summary
The general aim of this non interventional study is to clarify what are the current clinical treatment practices of Quetiapine Immediate Release and Quetiapine Extended Release. The primary objectives...
Eligibility Criteria
Inclusion
- Medication: Seroquel or Seroquel Prolong
- Diagnosis: F20-F29 or F30-F31 (ICD-10)
- In-patient
Exclusion
- None
Key Trial Info
Start Date :
August 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2010
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT00965536
Start Date
August 1 2009
End Date
December 1 2010
Last Update
February 16 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Lappeenranta, Finland